Riskpilot← Back to searchSign inGet full accessPharma4ever QA ApS
APSActiveCVR 39104644Hørkær 24, st.Engineering activities and related technical consultancy · NACE 7112Est. 20178 employeeswww.pharma4ever.com
Revenue 2024
DKK 11,5M
+33% vs 2023
EBITDA margin
27.9%
+45% vs 2023
Equity ratio
62.2%
Financial strength
Net profit 2024
DKK 2,5M
+45% vs 2023
| Revenue | DKK 11,5M | +33% |
| EBITDA | DKK 3,2M | +45% |
| Net profit | DKK 2,5M | +45% |
| Total assets | DKK 4,1M | +6% |
| Equity | DKK 2,6M | +41% |
| Employees | 8 | — |
Legal name
Pharma4ever QA ApS
CVR number
39104644
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
21. november 2017
Share capital
DKK 50.000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 bestyrelsesmedlemmer i forening eller af 1 bestyrelsesmedlem i forening med 1 direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at udføre QA- og RA-opgaver samt anden virksomhed, der efter bestyrelsens skøn er forbundet hermed.
Address
Hørkær 24, st.
Phone
+4542125853
Email
slp@pharma4ever.com
Website
www.pharma4ever.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.437 | 4.906 | 6.046 | 5.891 | 7.718 | 8.617 | 11.494 |
| Staff expenses | -2.341 | -3.462 | -3.997 | -4.269 | -5.147 | -6.402 | -8.283 |
| EBITDA | 2.096 | 1.445 | 2.049 | 1.622 | 2.571 | 2.215 | 3.212 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 2.096 | 1.445 | 2.049 | 1.622 | 2.571 | 2.215 | 3.212 |
| Net financials | -17 | -6 | -11 | -15 | -11 | 2 | 4 |
| Profit before tax | 2.079 | 1.439 | 2.038 | 1.606 | 2.560 | 2.217 | 3.216 |
| Tax | 460 | 318 | 449 | 354 | 565 | 489 | 709 |
| Net profit | 1.619 | 1.121 | 1.589 | 1.252 | 1.996 | 1.728 | 2.507 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 2.173 | 2.285 | 3.789 | 2.452 | 3.265 | 3.861 | 4.110 |
| Equity | 1.669 | 1.190 | 1.679 | 1.331 | 2.076 | 1.814 | 2.557 |
| Long-term debt | 0 | 53 | 233 | 0 | 0 | 0 | 0 |
| Short-term debt | 504 | 1.041 | 1.877 | 1.122 | 1.188 | 2.047 | 1.552 |
| Total debt | 504 | 1.095 | 2.110 | 1.122 | 1.188 | 2.047 | 1.552 |
EBITDA margin
27.9%
This company
15.8%
Market median
+77% vs market
20182024
Equity ratio
62.2%
This company
38.2%
Market median
+63% vs market
20182024
Return on equity
98.0%
This company
18.4%
Market median
+433% vs market
20182024
Net profit margin
21.8%
This company
8.1%
Market median
+169% vs market
20182024
Asset turnover
2.80×
This company
1.12×
Market median
+150% vs market
20182024
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-11-21 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SL Management | Management | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SLP Holding 2017 ApS | Company | 33.3% | 33.3% | 2017 |
Andresen Holding af 29. maj 2015 ApS | Company | 25.0% | 25.0% | 2017 |
BHP Holding ApS | Company | 25.0% | 25.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BHP Holding ApS
Pharma4ever QA ApS Board members of Pharma4ever QA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Lyngsø-Petersen | Management | 0 companies |
| Per Rønsholt Andresen | Board of Directors | 0 companies |
| Bo Hejgaard Pedersen | Board of Directors | 0 companies |